MG

Meera Gupta

Active Director Director DIN 01264014
DIN 01264014 First appointment Jan 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2007
Shareholding value •••• Premium profile

About Meera Gupta

Data last updated:

Meera Gupta is a Director at Booty Pharma Private Limited (since 2007). The company operates in Pharma. Booty Pharma Private Limited reported revenue of ₹1.87 Cr (FY 2024).

DIN 01264014
Primary Designation Director
Industry Pharma
First Appointment 31 Jan 2007
Oldest Company Age 31 yrs
Largest company Booty Pharma Private Limited · ₹1.87 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Booty Pharma Private Limited U24231UP1995PTC017861
Director31 Jan 20071995₹1.87 Cr (FY 2024)Active

Board colleagues of Meera Gupta

Directorship timeline

Open interactive timeline →
Booty Pharma Private Limited
Premium access

Shareholding and investment profile for Meera Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meera Gupta

Meera Gupta currently holds 1 directorship: Booty Pharma Private Limited (Director, since 31 Jan 2007, revenue ₹1.87 Cr (FY 2024)).

Meera Gupta was first appointed on 31 Jan 2007 as Director at Booty Pharma Private Limited.

The current boards of Meera Gupta's companies include Ravi Kant Gupta (Booty Pharma Private Limited), Reeshabh Gupta (Booty Pharma Private Limited), Shubham Gupta (Booty Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available